Related by context. All words. (Click for frequent words.) 66 HuMax CD# 65 JAK inhibitor 65 elotuzumab 64 BRAF inhibitor 64 tezampanel 64 Archexin 63 Azedra 62 torezolid phosphate 62 methylnaltrexone 62 cannabinor 62 pradefovir 62 PRT# 62 OHR/AVR# 62 Sym# 62 Mipomersen 62 Lupuzor 62 GED aPC 62 linaclotide 61 ularitide 61 CCX# 61 tiapamil 61 alvespimycin 61 IMA# 61 HuMax EGFr 61 huC# DM4 61 zanolimumab 61 ISIS # 61 ulimorelin 61 phase IIb 61 phase IIa clinical 61 INCB# [002] 61 ganetespib 61 Guanilib 61 entinostat 61 Traficet EN 61 MEK inhibitors 61 ATL# [001] 61 compound INCB# 61 PDE4 inhibitor 60 Clavis Pharma 60 Ceflatonin R 60 Dacogen injection 60 ASA# 60 HuMax CD4 60 AEG# 60 BAY #-# 60 Nanobody 60 axitinib 60 vidofludimus 60 XmAb# 60 INCB# [001] 60 Alocrest 60 Nuvion 60 Fibrillex TM 60 Phase IIa trials 60 Cinquil 60 PXD# 60 anticancer compound 60 SNT MC# 60 Phase Ib study 60 DDP# 60 oral prodrug 60 Proxinium TM 60 Phase 2b clinical trials 60 LEP ETU 60 RH1 60 RGB # 60 ACZ# 60 EnzymeRx 60 daclizumab 60 dirucotide 60 NNR Therapeutics 59 Ceflatonin 59 MNTX 59 pexiganan 59 L BLP# 59 phase IIb clinical 59 dacetuzumab 59 CEQ# 59 Xanafide 59 deforolimus 59 otelixizumab 59 obatoclax 59 luliconazole 59 CRLX# 59 MGCD# [001] 59 proteasome inhibitor 59 CDP# 59 lumiliximab 59 NGX# 59 Factor VIIa 59 lomitapide 59 R#/MEM # 59 radiation sensitizer 59 ATL# [002] 59 ASONEP 59 enzastaurin 59 baminercept 59 JAK2 inhibitors 59 INCB# [003] 59 Plicera 59 Aplidin 59 CytoFab 59 Perifosine 59 tranilast 59 RhuDex ® 59 PSN# [002] 59 teduglutide 59 OncoVEX 59 YONDELIS 59 PRTX 59 PHX# 59 UPLYSO 59 terlipressin 59 CCR9 antagonist 59 CA4P 59 Annamycin 59 isoform selective 59 Ramoplanin 59 JAK inhibitors 58 ruxolitinib 58 volociximab 58 EndoTAG TM -1 58 OncoVEX GM CSF 58 elinogrel 58 humanized monoclonal antibody 58 Panzem 58 Icatibant 58 drug ISA# 58 ocrelizumab 58 TG# [001] 58 glucokinase activator 58 amrubicin 58 Phase IIb clinical trials 58 HCD# [002] 58 Nanobodies 58 Bortezomib 58 SARMs 58 AQ4N 58 ACV1 58 Virulizin 58 GALNS 58 orally bioavailable 58 romidepsin 58 Relivar 58 fostamatinib 58 bardoxolone 58 Virulizin ® 58 metaglidasen 58 JAK1 58 GAP #B# 58 FOLOTYN ® 58 tubulin inhibitor 58 LY# [003] 58 teriflunomide 58 pomalidomide 58 Firazyr 58 Tezampanel 58 liposomal formulation 58 polymerase inhibitor 58 docetaxel Taxotere R 58 Milnacipran 58 IAP inhibitors 58 oncology indications 58 tanespimycin 58 vascular disrupting agents 58 AP# [003] 58 danoprevir 58 Troxatyl 58 EOquin 58 Benlysta belimumab 58 Carfilzomib 58 HGS# 58 PLX# 58 octreotide implant 58 Phenoptin 58 Phase 2b trial 58 Amplimexon 58 Aviptadil 58 Loramyc 58 forodesine 58 VEGF Trap 58 blinatumomab 58 MEK inhibitor 58 KNS # 58 Bicifadine 58 MAXY alpha 58 INT# [002] 58 investigational monoclonal antibody 58 silodosin 58 Ostabolin C 58 pan HDAC inhibitor 58 Phase Ib clinical 58 investigational humanized monoclonal antibody 58 Evoltra ® 58 CytoFabTM 58 AeroLEF TM 58 reslizumab 58 investigational therapies 58 Vandetanib 58 Insegia 57 ENMD # 57 Pimavanserin 57 RNAi therapeutic targeting 57 Aflibercept 57 alemtuzumab Campath 57 faropenem 57 Phase 2a 57 DXL# 57 RSD# 57 vemurafenib 57 cMET 57 Retigabine 57 Pertuzumab 57 SAR# [002] 57 Bapineuzumab 57 NP2 Enkephalin 57 non nucleoside HCV 57 Dasatinib 57 ARRY 57 biologic therapies 57 LAS# [002] 57 clofarabine 57 Phase 2b 57 p# inhibitor 57 hematological indications 57 TG# [003] 57 atacicept 57 tocilizumab 57 Aurexis 57 CR# vcMMAE 57 Viramidine 57 Phase Ib 57 Amrubicin 57 PEG SN# 57 Aclidinium 57 tafamidis 57 KIACTA ™ 57 Genasense ® 57 Factor Xa inhibitor 57 LE DT 57 Radezolid 57 atrasentan 57 Folotyn 57 Serdaxin 57 Omnitarg 57 PLK1 SNALP 57 Asentar 57 preclinical 57 PI3K inhibitor 57 Arcalyst 57 outlicensing 57 eltrombopag 57 Azedra TM 57 Tofacitinib 57 Civacir 57 Dynogen 57 ELACYT 57 Targretin 57 pegylated interferons 57 relapsed multiple myeloma 57 talactoferrin 57 Zerenex 57 Cerimon 57 oral taxane 57 RPL# 57 cancer immunotherapies 57 Atiprimod 57 IMGN# 57 safinamide 57 TKB# 57 mertansine 57 leading oral taxane 57 Oglemilast 57 ProLindac TM 57 phase IIb trial 57 Zybrestat 57 Ceftaroline 57 NXL# 57 Daclizumab 57 ATL/TV# 57 Nasulin 57 DCVax R 57 Epratuzumab 57 CIMZIA ™ 57 GRN# 57 BEMA TM Fentanyl 57 HZT 57 HspE7 57 MAP# 57 eniluracil 57 PEG Interferon lambda 57 Fx #A 57 Teflaro 57 Debio 57 VAPRISOL 57 Symadex 57 relapsed leukemia 57 Elagolix 57 XL# XL# 57 ProSavin 57 Vitaxin 57 HuLuc# 57 Aurora kinase 57 Genz # 57 Panitumumab 57 betrixaban 57 Phase IIa trial 57 Lixivaptan 57 CytoFab ™ 57 oral antiviral 57 refractory gout 57 Amigal 57 LymphoStat B belimumab 57 RNAi therapeutic targeting PCSK9 57 Tamibarotene 57 Ustekinumab 57 sunitinib malate 57 recurrent glioblastoma 57 BCX# 57 Phase IIb trials 57 Santhera 57 brivaracetam 57 PEGylated Fab fragment 57 phase IIa 57 AKT inhibitor 57 farletuzumab 57 veltuzumab 57 Actilon 56 PREOS R 56 aclidinium 56 Golimumab 56 JNJ Q2 56 velaglucerase alfa 56 tivozanib 56 Nanobodies R 56 Atrasentan 56 rilonacept 56 Anticalin 56 Ophena TM 56 PF # [001] 56 Urocidin 56 lurasidone 56 PI3K/Akt pathway inhibitor 56 PREOS 56 TRC# 56 HQK 56 omacetaxine 56 Indaflex TM 56 histone deacetylase HDAC inhibitor 56 epothilones 56 XL# [003] 56 Nexavar ® 56 PEGylated 56 Phase III confirmatory 56 intranasal formulation 56 LAF# 56 antisense drug 56 EGFR inhibitors 56 ceftazidime 56 Marqibo 56 SUTENT 56 EP #R 56 RoActemra 56 Chrysalin 56 eprotirome 56 ThermoDox ® 56 PROMACTA 56 haematological cancers 56 Argatroban 56 oral picoplatin 56 prostone 56 HGS ETR2 56 Ambrisentan 56 seliciclib CYC# 56 regorafenib 56 anti angiogenic agents 56 HCV protease inhibitors 56 selective androgen receptor modulator 56 CoTherix 56 Phase IIa clinical 56 EOquin TM 56 Cloretazine R VNP#M 56 Velcade bortezomib 56 bendamustine 56 ALN TTR# 56 CD# CEA 56 CD# antibody [001] 56 NVA# 56 receptor tyrosine kinase inhibitor 56 diabetic neuropathic pain 56 Phase III clinical 56 eosinophilic asthma 56 GW# [003] 56 RhuDex 56 lesinurad 56 Angiocept 56 alvimopan 56 Seliciclib 56 VA# [002] 56 ONCONASE R 56 sapacitabine 56 HGS ETR1 56 apremilast 56 Panzem R 56 urocortin 2 56 Proquin XR 56 Tesetaxel 56 CGEN # 56 Prestara 56 investigational pan BCR 56 ambrisentan 56 preclinically 56 Desmoteplase 56 Gleevec imatinib mesylate 56 TKM ApoB 56 bicifadine 56 Allovectin 7 56 CYT# potent vascular disrupting 56 JAK3 56 Ophthotech 56 ozarelix 56 ARIKACE ™ 56 oxypurinol 56 Pradefovir 56 CINOD 56 Tavocept 56 Gattex 56 Onconase 56 Belinostat 56 Romidepsin 56 ProMune 56 Hedgehog antagonist 56 neratinib 56 cetuximab Erbitux 56 EVIZON 56 BRIM2 56 Davanat 56 PS# [001] 56 Cimzia ® certolizumab pegol 56 ACAPODENE 56 PDE4 inhibitors 56 preclinical compounds 56 AEGR 56 visilizumab 56 commercialize dutogliptin 56 dexpramipexole 56 antisense drugs 56 RITUXAN 56 Blinatumomab 56 ZACTIMA 56 Linaclotide 56 MORAb 56 EndoTAG TM 56 HCV protease inhibitor 56 PI3K inhibitors 56 investigational compounds 56 novel oral anticoagulant 56 anti angiogenic therapy 56 Phase 1b 56 IIa trial 56 Hsp# inhibitors 56 Anthera 56 targeting CD# 56 Scancell 56 Ofatumumab 56 RAPAFLO 56 aclidinium bromide 56 registrational 56 CCX# B 55 injectable formulation 55 Firdapse 55 REP# 55 rFIXFc 55 valopicitabine 55 IIa trials 55 PSMA ADC 55 incyclinide 55 S/GSK# 55 Nanobody ® 55 Revimmune 55 AERx iDMS 55 Panzem R NCD 55 Zingo TM 55 DR Cysteamine 55 Diamyd ® 55 Genentech Roche 55 CINTREDEKIN BESUDOTOX 55 cysteamine 55 ofatumumab 55 anticoagulant reversing agent 55 crofelemer 55 trastuzumab DM1 55 Phase III 55 BAL# [002] 55 abiraterone acetate 55 angiogenesis inhibitor 55 Phase #/#a 55 ThermoDox R 55 metastatic hormone refractory 55 tasocitinib 55 ONCONASE 55 dose escalation Phase 55 Interferon alpha 55 preclinical studies 55 elesclomol 55 Tyrima 55 ALN PCS 55 Hsp# inhibition 55 AZX# 55 Phase 2b study 55 Eltrombopag 55 investigational compound 55 TRAIL receptor antibodies 55 BZL# 55 Aegera 55 protein kinase inhibitor 55 favorable pharmacokinetic profile 55 Xeloda capecitabine 55 Neulasta ® 55 RAPTIVA 55 rxRNA 55 Pazopanib 55 MDV# 55 eculizumab 55 LymphoStat B 55 DU #b 55 MabCampath 55 Alemtuzumab 55 Voreloxin 55 Gleevec resistant 55 TPI ASM8 55 GAMMAGARD 55 nalbuphine ER 55 RNAi therapeutic 55 Cimzia TM 55 Onalta 55 Aliskiren 55 somatostatin analogue 55 BrachySil TM 55 Randomized Phase 55 Synavive 55 NEUGENE 55 LEVADEX TM 55 PrevOnco 55 renin inhibitor 55 Phase 2a trial 55 IL# PE#QQR 55 Oncolys 55 Zenvia Phase III 55 Tasimelteon 55 hematological cancers 55 pertuzumab 55 BCR ABL inhibitors 55 Actemra tocilizumab 55 ADAGIO study 55 TEMODAL 55 Plecanatide 55 Spiegelmer ® 55 Alpharadin 55 PEG PAL 55 Aplidin R 55 Catena ® 55 triphendiol 55 #D#C# 55 including eniluracil ADH 55 Pemetrexed 55 Ocrelizumab 55 Raptiva ® 55 Rebif ® 55 TOCOSOL Paclitaxel 55 OMNARIS Nasal Spray 55 dextromethorphan quinidine 55 CRx 55 tesetaxel 55 vascular disrupting agent 55 Cancidas 55 HSP# inhibitor 55 severe gastroparesis 55 Vaccinex 55 pralatrexate 55 TRX1 55 Fampridine 55 ITAX 55 Tranzyme 55 cancer neuroendocrine tumor 55 BMS # 55 leukemia AML 55 Ixempra 55 PEP# [003] 55 RLY# 55 Pivotal Phase III 55 JAK2 inhibitor 55 Avastin bevacizumab 55 nonclinical studies 55 Behcet uveitis 55 Abbokinase 55 preclinical efficacy 55 Pirfenidone 55 rNAPc2 55 Rescula 55 Actemra 55 BNC# 55 RELOVAIR ™ 55 Excaliard 55 retinal vein occlusion induced 55 oral PTH 55 Phase IIIb clinical 55 rasagiline tablets 55 DCCR 55 class mGluR5 inhibitor 55 efalizumab 55 Phase 1b trial 55 ceftaroline 55 Emselex 55 Dapagliflozin 55 IMC #B 55 antibody MAb 55 pitavastatin 55 T DM1 55 Tarvacin 55 milnacipran 55 Orazol 55 Vorinostat 55 immatics 55 NUVIGIL 55 Phase IIb clinical 55 novel histone deacetylase 55 Erlotinib 55 CIMZIA TM 55 acute PAO 55 elvucitabine 55 Cethrin 55 Tarceva TM 55 tramiprosate Alzhemed TM 55 DB# [003] 55 confirmatory Phase III 55 Novexel 55 Preclinical studies suggest 55 CORT # 55 telomerase therapeutic 55 Cetrorelix 55 TH# [003] 55 Olaparib 55 Nexavar sorafenib 55 Vasovist 55 HoFH 55 IV Busulfex 55 depsipeptide 55 multi kinase inhibitor 55 Evoltra 55 adipiplon 55 GLPG# 55 AZILECT ® 55 LY# [002] 55 OvaRex ® MAb 55 Bezielle 55 R roscovitine 55 Helsinn Healthcare 55 talabostat 55 midstage trials 55 refractory CLL 55 Phase 1a 55 Tracleer r 55 Cimzia ® 55 Phase IIb 55 OX1 55 ridaforolimus 55 rFVIIIFc 55 opioid induced bowel dysfunction 55 CYT# 55 OXi# 55 Tolvaptan 55 Plexxikon 55 Arikace 55 rhMBL 55 AzaSite Xtra 55 Allovectin 7 R 55 davunetide intranasal AL 55 RAPTIVA R 55 AVN# [001] 55 Omacetaxine 55 Phase 1b clinical trials 55 GSK# [002] 55 Mycograb 55 Zenvia ™ 55 PARP inhibitors 55 EndoTAG 55 KIACTA TM 55 Xyfid TM 55 amifampridine phosphate 55 Crofelemer 55 Ridaforolimus 55 Doxorubicin 55 subcutaneous formulation 55 PGL# 55 Saforis 55 advanced carcinoid 55 OMP #M# 55 JZP 55 selective S#P# receptor agonist 55 kinase inhibitor 55 Opexa 55 PRX# 55 dutogliptin 55 Telaprevir 55 IDX# 55 Æterna Zentaris 55 MEK inhibitor RDEA# 55 Virulizin R 55 WILEX 55 siRNA therapeutics 55 neovascular diseases 55 anticancer therapy 55 flupirtine 55 Fabry Disease 55 tamibarotene 55 TRV# [001] 55 Oxypurinol 55 ESBA# 55 albinterferon alfa 2b 55 zileuton 54 Exelixis XL# 54 generation proteasome inhibitor 54 Anavex #-# 54 lixivaptan 54 metastatic renal cell carcinoma 54 pseudobulbar affect PBA 54 HIV integrase inhibitor 54 Pralatrexate 54 XL# anticancer compounds 54 Zolinza 54 OGeS 54 Exherin 54 pharmacokinetic PK study 54 Xiaflex 54 AVE# 54 Oral NKTR 54 ProLindac 54 PLX cells 54 Phase 2a clinical 54 sodium thiosulfate STS 54 LymphoStat B TM 54 GLYX 54 MYDICAR 54 phase 2a 54 tipifarnib 54 GDIR 54 Kissei Pharmaceutical 54 placebo controlled Phase 54 Vivecon 54 MabThera rituximab 54 NTDDS 54 VentiRx 54 GSK '# 54 topical NSAID 54 A3 adenosine receptor 54 deferiprone 54 epothilone 54 Fodosine 54 SAR# [004] 54 Inhalation Solution 54 tesmilifene 54 URG# 54 Adentri 54 ALN RSV# 54 docetaxel Taxotere ® 54 Aurora Kinase 54 MyVax R 54 Sutent sunitinib 54 Octreotide 54 oral salmon calcitonin 54 humanized anti 54 rhC1INH 54 RAPAFLO R 54 ELND# 54 tosedostat 54 Humira adalimumab 54 GV# [001] 54 sJIA 54 Avanafil 54 Viprinex 54 Phase 2b clinical 54 GLP toxicology studies 54 Zoraxel 54 lupus nephritis 54 Xerecept 54 golimumab 54 Quark Biotech 54 Abiraterone 54 oral ridaforolimus 54 mAb 54 relapsing remitting multiple sclerosis 54 monoclonal antibody therapeutics 54 Resten NG 54 MBP# [001] 54 Onco TCS 54 Miraxion 54 liposomal ciprofloxacin 54 Phase IIa 54 Personalized Immunotherapy 54 Vidaza azacitidine 54 TACI Ig 54 Revlimid lenalidomide 54 tolvaptan 54 OMAPRO 54 FOLOTYN 54 sorafenib Nexavar 54 Meets Primary Endpoint 54 CB2 selective receptor agonist 54 ecallantide 54 Mpex 54 Evoltra TM 54 neuropathic pain 54 Trizytek 54 acetonide FA 54 Pfizer Sutent 54 iSONEP 54 AutoloGel tm System 54 HCV polymerase inhibitor 54 Ziopharm 54 Friedreich Ataxia FRDA 54 Affinitak 54 pharmacological chaperone 54 elacytarabine 54 Aurora kinase inhibitor 54 Androxal TM 54 fipamezole 54 CBLC# 54 fostamatinib disodium 54 anticancer agent 54 anticancer therapies 54 IRX 2 54 Cannabinor 54 Sublinox 54 Laquinimod 54 Pharmacokinetic studies 54 carcinoid syndrome 54 thalidomide Thalomid 54 budesonide foam 54 Ventavis 54 panitumumab Vectibix 54 Antisense 54 Safinamide 54 aHUS 54 Neurodex 54 BioVant 54 ADP receptor antagonist 54 nucleoside analog 54 TBC# 54 HDAC inhibition 54 EGS# 54 TREANDA 54 proteasome inhibitor bortezomib 54 perifosine 54 Phase IIB 54 Glufosfamide 54 Phase #/#a trial 54 Vicinium TM 54 Capesaris 54 ruboxistaurin 54 Cardio Vascu Grow 54 thetreatment 54 biologic therapy 54 lintuzumab 54 IMiD 54 ORENCIA R 54 Iloperidone 54 TRIOLEX 54 AzaSite Plus 54 Telatinib 54 glufosfamide 54 Genentech Rituxan 54 Leukine 54 AMD# [003] 54 bendamustine HCl 54 novel nucleoside analog 54 Aryplase 54 aflibercept VEGF Trap 54 VPRIV 54 hematological malignancy 54 vinorelbine tartrate 54 Dacogen decitabine 54 Retavase 54 hypoxia activated prodrug 54 MLN# 54 Triolex 54 Tarceva erlotinib 54 polymerase inhibitors 54 IAP inhibitor 54 IND submission 54 carfilzomib 54 mTOR inhibitor 54 inhibitor RG# 54 rilpivirine 54 Phase Ib clinical trials 54 Quinamed 54 micafungin 54 Thiarabine 54 IFN α 54 bortezomib Velcade 54 RP# [002] 54 mGluR2 positive 54 TKM PLK1 54 oral anticancer 54 PF # [002] 54 mGluR5 NAM 54 Valopicitabine 54 JP-#/fipamezole 54 IPLEX 54 nitric oxide donating prostaglandin 54 nebivolol 54 BiTE antibody 54 lapatinib Tykerb 54 Onalta ™ 54 CAMPATH 54 XmAb 54 MET inhibitor 54 antisense inhibitor 54 P#X# antagonist 54 Trofex 54 ponatinib 54 targeted radiotherapeutic 54 AMPA kainate 54 Tocilizumab 54 ONTAK 54 BENLYSTA ® 54 Cimzia certolizumab pegol 54 Silence Therapeutics 54 SU# [003] 54 Pafuramidine 54 oral fludarabine 54 ciclesonide 54 apaziquone 54 NovaBay Aganocide compounds 54 delafloxacin 54 invasive candidiasis 54 custirsen 54 mixed dyslipidemia 54 homozygous familial hypercholesterolemia 54 MoxDuo 54 Varespladib 54 Zensana TM 54 Cx# [002] 54 PAOD 54 apricitabine 54 CLL SLL 54 dasatinib Sprycel 54 placebo controlled clinical 54 radezolid 54 psoriasis rheumatoid arthritis 54 drug conjugate 54 Addrenex 54 Treanda 54 Clevudine 54 midstage clinical 54 Alvesco R 54 Zelrix 54 oncolytic virus therapy 54 retigabine 54 Zenvia TM 54 ZK EPO 54 mecamylamine 54 CDK inhibitor 54 Adlea 54 ophthalmic indications 54 MOZOBIL 54 6R BH4 54 Exherin TM 54 Phase Ib II 54 TNF Tumor Necrosis Factor 54 Aloxi injection 54 Fibrillex 54 PROCHYMAL 54 olaparib 54 EPX # 54 alagebrium 54 Combidex 54 Ilaris 54 romazarit 54 Sudhir Agrawal D.Phil 54 MT# MEDI 54 Stelara 54 Toraymyxin TM 54 ostarine 54 ibudilast 54 Cethrin R 54 evaluating tivozanib 54 OvaRex R 54 crizotinib PF # 54 Vaprisol 54 myeloproliferative disorders 54 Entereg R 54 Kyowa Hakko Kirin 54 highly selective adenosine 54 2DG 54 Viprinex TM 54 IPL# 54 Unit Dose Budesonide